The company's challenges might not be insurmountable, but they are serious enough to warrant a healthy dose of skepticism.
Automated insulin delivery systems can help pregnant women with type 1 diabetes manage their glucose during gestation.
TNDM's global expansion and strategic integrations fuel growth potential, even as pump reliance and macro pressures weigh on ...
In connection with the offering, Modular Medical has granted the underwriter a 30-day option to purchase up to an additional 15% of common shares and/or warrants at the public offering price, less ...
SAN DIEGO, CA / ACCESS Newswire / December 9, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), an insulin delivery technology company with the first FDA-cleared patch pump designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback